DBD (DBD) Stock Analysis

DBD (DBD) is a publicly traded company in the Sector Equity sector. It trades at $82.28, carries a market capitalization of $2.87B, a price-to-earnings ratio of 28.58. This page summarizes the public market data, fundamentals, and frequently asked questions for DBD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: Sector Equity - Technology

Key Metrics

• Price: $82.28
• Market Cap: $2.87B
• P/E Ratio: 28.58
• EPS: $2.90
• 52-Week High: $89.05
• 52-Week Low: $49.15

GNG Research Analysis

GNG Research scores DBD (DBD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DBD.

Frequently Asked Questions

Does DBD pay dividends?

DBD (DBD) does not currently pay a regular dividend.

What is DBD's P/E ratio?

DBD has a price-to-earnings (P/E) ratio of 28.58.

What is DBD's market cap?

DBD (DBD) has a market capitalization of $2.87B with a current stock price of $82.28.